Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens

Journal of Neurochemistry

Volumn 127, Issue 6, 2013, Pages 762-771

  Perez, Xiomara A ^a   McIntosh, J Michael ^b,c   Quik, Maryka ^a  

^a SRI INTERNATIONAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

addiction; nicotine; nicotinic receptors; nucleus accumbens; voltammetry

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; DOPAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA6BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOSENSITIVITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG BLOOD LEVEL; DRUG MECHANISM; EVOKED RESPONSE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; TOBACCO DEPENDENCE;

RATTUS;

EID: 84890126258     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12442     Document Type: Article

References (58)

1. Balfour D. J., (2009) The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb. Exp. Pharmacol. 192, 209-233.
2. Benowitz N. L., (2010) Nicotine addiction. N. Engl. J. Med. 362, 2295-2303.
3. Benwell M. E., and, Balfour D. J., (1997) Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur. J. Pharmacol. 325, 13-20.
4. Brunzell D. H., (2012) Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype. Nicotine Tob. Res. 14, 1258-1269.
5. Cachope R., Mateo Y., Mathur B. N., Irving J., Wang H. L., Morales M., Lovinger D. M., and, Cheer J. F., (2012) Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep. 2, 33-41.
6. Changeux J. P., (2010) Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat. Rev. Neurosci. 11, 389-401.
7. Corrigall W. A., Franklin K. B., Coen K. M., and, Clarke P. B., (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285-289.
8. Cragg S. J., (2003) Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J. Neurosci. 23, 4378-4385.
9. Cragg S. J., Nicholson C., Kume-Kick J., Tao L., and, Rice M. E., (2001) Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J. Neurophysiol. 85, 1761-1771.
10. De Biasi M., and, Dani J. A., (2011) Reward, addiction, withdrawal to nicotine. Annu. Rev. Neurosci. 34, 105-130.
11. Dhelaria R. K., Friderici J., Wu K., Gupta E., Khan C., and, Rothberg M. B., (2012) Effectiveness of varenicline for smoking cessation at 2 urban academic health centers. Eur. J. Intern. Med. 23, 461-464.
12. Di Chiara G., Bassareo V., Fenu S., et al,. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1), 227-241.
13. Epping-Jordan M. P., Picciotto M. R., Changeux J. P., and, Pich E. M., (1999) Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology 147, 25-26.
14. Exley R., and, Cragg S. J., (2008) Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br. J. Pharmacol. 153 (Suppl 1), S283-S297.
15. Exley R., Clements M. A., Hartung H., McIntosh J. M., and, Cragg S. J., (2008) Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33, 2158-2166.
16. Exley R., Maubourguet N., David V., et al,. (2011) Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine. Proc. Natl Acad. Sci. USA 108, 7577-7582.
17. Gotti C., Guiducci S., Tedesco V., et al,. (2010) Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J. Neurosci. 30, 5311-5325.
18. Grace A. A., (2000) The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95 (Suppl 2), S119-S128.
19. Grady S. R., Wageman C. R., Patzlaff N. E., and, Marks M. J., (2012) Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include alpha5 or alpha6 subunits and that mediate synaptosomal neurotransmitter release. Neuropharmacology 62, 1935-1943.
20. Hopkins T. J., Rupprecht L. E., Hayes M. R., Blendy J. A., and, Schmidt H. D., (2012) Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacology 37, 2310-2321.
21. Jackson K. J., McIntosh J. M., Brunzell D. H., Sanjakdar S. S., and, Damaj M. I., (2009) The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J. Pharmacol. Exp. Ther. 331, 547-554.
22. Jarvik M. E., Madsen D. C., Olmstead R. E., Iwamoto-Schaap P. N., Elins J. L., and, Benowitz N. L., (2000) Nicotine blood levels and subjective craving for cigarettes. Pharmacol. Biochem. Behav. 66, 553-558.
23. John C. E., Budygin E. A., Mateo Y., and, Jones S. R., (2006) Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J. Neurochem. 96, 267-282.
24. Keating G. M., and, Lyseng-Williamson K. A., (2010) Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Pharmacoeconomics 28, 231-254.
25. Kuryatov A., and, Lindstrom J., (2011) Expression of functional human alpha6beta2beta3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers. Mol. Pharmacol. 79, 126-140.
26. Liu L., Zhao-Shea R., McIntosh J. M., Gardner P. D., and, Tapper A. R., (2012) Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing alpha4 and alpha6 subunits. Mol. Pharmacol. 81, 541-548.
27. Matta S. G., Balfour D. J., Benowitz N. L., et al,. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190, 269-319.
28. Meyer E. L., Yoshikami D., and, McIntosh J. M., (2008) The neuronal nicotinic acetylcholine receptors alpha4 and alpha6 differentially modulate dopamine release in mouse striatal slices. J. Neurochem. 105, 1761-1769.
29. Mills E. J., Wu P., Lockhart I., Thorlund K., Puhan M., and, Ebbert J. O., (2012) Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis. Ann. Med. 44, 588-597.
30. Paolini M., and, De Biasi M., (2011) Mechanistic insights into nicotine withdrawal. Biochem. Pharmacol. 82, 996-1007.
31. Perez X. A., Bordia T., McIntosh J. M., Grady S. R., and, Quik M., (2008a) Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function. Mol. Pharmacol. 74, 844-853.
32. Perez X. A., Parameswaran N., Huang L. Z., O'Leary K. T., and, Quik M., (2008b) Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates. J. Neurochem. 105, 1861-1872.
33. Perez X. A., O'Leary K. T., Parameswaran N., McIntosh J. M., and, Quik M., (2009) Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment. Mol. Pharmacol. 75, 938-946.
34. Perez X. A., Bordia T., McIntosh J. M., and, Quik M., (2010) alpha6ss2* and alpha4ss2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease. Mol. Pharmacol. 78, 971-980.
35. Perez X. A., Ly J., McIntosh J. M., and, Quik M., (2012) Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens. J. Pharmacol. Exp. Ther. 342, 335-344.
36. Picciotto M. R., Zoli M., Rimondini R., Lena C., Marubio L. M., Pich E. M., Fuxe K., and, Changeux J. P., (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
37. Pons S., Fattore L., Cossu G., Tolu S., Porcu E., McIntosh J. M., Changeux J. P., Maskos U., and, Fratta W., (2008) Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci. 28, 12318-12327.
38. Quik M., and, Wonnacott S., (2011) alpha6beta2* and alpha4beta2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol. Rev. 63, 938-966.
39. Quik M., Polonskaya Y., Gillespie A., K Lloyd G., and, Langston J. W., (2000) Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neuroscience, 100, 63-72.
40. Quik M., Polonskaya Y., Kulak J. M., and, McIntosh J. M., (2001) Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey. J. Neurosci. 21, 5494-5500.
41. Rice M. E., and, Cragg S. J., (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7, 583-584.
42. Rice M. E., Patel J. C., and, Cragg S. J., (2011) Dopamine release in the basal ganglia. Neuroscience 198, 112-137.
43. Sellings L. H., Baharnouri G., McQuade L. E., and, Clarke P. B., (2008) Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens. Eur. J. Neurosci. 28, 342-352.
44. Sofuoglu M., and, Mooney M., (2009) Cholinergic functioning in stimulant addiction: implications for medications development. CNS Drugs 23, 939-952.
45. Tapper A. R., McKinney S. L., Nashmi R., et al,. (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306, 1029-1032.
46. Threlfell S., Lalic T., Platt N. J., Jennings K. A., Deisseroth K., and, Cragg S. J., (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75, 58-64.
47. Tuesta L. M., Fowler C. D., and, Kenny P. J., (2011) Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem. Pharmacol. 82, 984-995.
48. Wightman R. M., and, Zimmerman J. B., (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15, 135-144.
49. Wise R. A., (2009) Roles for nigrostriatal-not just mesocorticolimbic- dopamine in reward and addiction. Trends Neurosci. 32, 517-524.
50. Yorgason J. T., Espana R. A., and, Jones S. R., (2011) Demon Voltammetry and Analysis software: Analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J. Neurosci. Methods 202, 158-164.
51. Zhang H., and, Sulzer D., (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7, 581-582.
52. Zhang L., Zhou F. M., and, Dani J. A., (2004) Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release. Mol. Pharmacol. 66, 538-544.
53. Zhang L., Doyon W. M., Clark J. J., Phillips P. E., and, Dani J. A., (2009a) Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol. Pharmacol. 76, 396-404.
54. Zhang T., Zhang L., Liang Y., Siapas A. G., Zhou F. M., and, Dani J. A., (2009b) Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J. Neurosci. 29, 4035-4043.
55. Zhang L., Dong Y., Doyon W. M., and, Dani J. A., (2011) Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol. Psychiatry 71, 184-191.
56. Zhao-Shea R., Liu L., Soll L. G., et al,. (2011) Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36, 1021-1032.
57. Zhou F. M., Liang Y., and, Dani J. A., (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4, 1224-1229.
58. Zhu S. H., Lee M., Zhuang Y. L., Gamst A., and, Wolfson T., (2012) Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob. Control 21, 110-118.